Alistair's Feed
May 19, 2014

AstraZeneca tows FTSE lower after takeover snub

LONDON (Reuters) – Britain’s top shares fell on Monday, dented by a sharp drop in pharmaceutical firm AstraZeneca after it rejected rival Pfizer’s higher takeover bid.

AstraZeneca dived 10.5 percent after turning down Pfizer’s 55 pounds/share take-it-or-leave-it offer.

May 19, 2014

AstraZeneca tows Britain’s FTSE lower after takeover snub

LONDON, May 19 (Reuters) – Britain’s top shares fell on
Monday, dented by a sharp drop in pharmaceutical firm
AstraZeneca after it rejected rival Pfizer’s higher takeover
bid.

AstraZeneca dived 10.5 percent after turning down
Pfizer’s 55 pounds/share take-it-or-leave-it offer.

May 19, 2014

AstraZeneca pegs back FTSE after takeover snub

LONDON (Reuters) – Britain’s top shares fell on Monday, pressured by a sharp drop in pharmaceutical firm AstraZeneca after it rejected rival Pfizer’s higher takeover bid.

AstraZeneca dived 12.9 percent after turning down Pfizer’s 55 pounds/share take-it-or-leave-it offer.

May 19, 2014

AstraZeneca pegs back Britain’s FTSE after takeover snub

LONDON, May 19 (Reuters) – Britain’s top shares fell on
Monday, lagging major European indexes on a sharp drop in
pharmaceutical firm AstraZeneca after it rejected rival Pfizer’s
higher takeover bid.

AstraZeneca dived 13.4 percent after turning down
Pfizer’s 55 pounds/share take-it-or-leave-it offer.

Apr 29, 2014

Tech boosts European shares on Nokia, Infineon results

LONDON, April 29 (Reuters) – European shares rose on
Tuesday, led by tech stocks as estimate-topping results from
chipmaker Infineon and telecommunication gear maker
Nokia brightened the outlook for the sector.

Infineon and Nokia were among the top risers on the
pan-European FTSEurofirst 300 index after they reported
quarterly earnings boosted respectively by demand from
automotive and industrial customers and by software deals.

Apr 28, 2014

AstraZeneca bid supports FTSE 100 despite ripples from Russian sanctions

LONDON, April 28 (Reuters) – AstraZeneca shares surged to
boost Britain’s top share index on Monday, after U.S. rival
Pfizer said it wanted to buy the drugmaker.

The FTSE 100 looked set to post a new 7-week closing
high, despite a volatile afternoon session as investors digested
new sanctions on Russia from the United States.

Apr 28, 2014

AstraZeneca keeps FTSE near seven-week highs

LONDON (Reuters) – AstraZeneca shares surged to keep Britain’s top share index close to seven-week highs on Monday, after U.S. rival Pfizer said it wanted to buy the drugmaker.

Pfizer confirmed on Monday it had approached AstraZeneca in January and said it had contacted the company again on April 26 seeking discussions about a takeover.

Apr 28, 2014

AstraZeneca bid confirmation keeps FTSE 100 near 7-week highs

LONDON, April 28 (Reuters) – AstraZeneca shares surged to
keep Britain’s top share index close to seven-week highs on
Monday, after U.S. rival Pfizer said it wanted to buy
the drugmaker.

Pfizer confirmed on Monday it had approached AstraZeneca in
January and said it had contacted the company again on April 26
seeking discussions about a takeover.

Apr 25, 2014

European shares slip as Ukraine crisis deepens

LONDON/PARIS, April 25 (Reuters) – German stocks led
European shares lower on Friday as new signs of violence in
Ukraine hit sentiment, although equities remained underpinned by
corporate takeover activity.

Ukrainian forces killed up to five pro-Moscow rebels on
Thursday, prompting Russia to launch army drills near the
border. In response, the United States said on Friday it will
press European allies to impose more sanctions if Russia steps
up action in Ukraine.

Apr 23, 2014

Earnings boost to help German shares overtake peripheral peers

LONDON, April 23 (Reuters) – German shares may overtake
their Italian and Spanish peers as Europe’s star performers this
quarter, boosted by better corporate earnings at a time when
expensive valuations are making investors more selective.

German companies are seen beating consensus predictions with
their first quarter earnings while numbers from firms in Italy
and Spain are set to fall short of expectations, according to
estimates from the most accurate analysts aggregated by Thomson
Reuters StarMine.

    • About Alistair

      "Alistair Smout is working on the Investment and Emerging Markets for Reuters Europe over the summer. He specialises in Africa and Europe."
    • More from Alistair

    • Follow Alistair